Biomarkers of aging
back to main page
Aging biomarkers are measurable biological indicators that reflect the rate of the body's aging processes at cellular, molecular, metabolic, and tissue levels. Unlike chronological age, they determine biological age, which is the actual functional state of the organism. The analysis of biomarkers enables the assessment of cell condition, the efficiency of organ systems, the level of chronic inflammation, oxidative stress, or the regenerative capacity of tissues. In longevity medicine, biomarkers play a significant role in identifying accelerated aging, assessing the risk of lifestyle diseases, and monitoring the effectiveness of health-promoting interventions. They are also becoming increasingly important in dermatology and aesthetic medicine, where they help assess the biological age of the skin and plan personalized anti-aging therapies.
Biomarkers of aging – what are they?
A biomarker of aging is an objective biological parameter that allows for the assessment of the degree of advancement of the body's aging processes. It should reflect changes occurring with age, correlate with the risk of age-related diseases, and enable monitoring the impact of therapy or lifestyle on the body.
Modern gerontology distinguishes several key mechanisms of aging, referred to as the hallmarks of aging. These include, among others:
- telomere shortening,
- genomic instability,
- mitochondrial dysfunction,
- chronic inflammation (inflammaging),
- oxidative stress,
- autophagy disorders,
- cellular senescence,
- epigenetic changes.
Biomarkers of aging enable the assessment of the intensity of these processes. They can be determined in blood, saliva, urine, tissues, or through advanced imaging and genetic testing.
In clinical practice, biomarkers are used for:
- biological age assessment,
- identification of individuals with accelerated aging,
- predicting the risk of metabolic and cardiovascular diseases,
- monitoring the effects of longevity therapies,
- planning preventive measures,
- assessing the quality of skin aging.
Modern medicine is moving away from perceiving aging solely as a chronological process. The assessment of the quality of body functioning and the regenerative capacities of cells and tissues is becoming increasingly important.
Biomarkers of aging – types and classification
Aging biomarkers can be divided into several groups depending on the biological level they concern.
Molecular and genetic biomarkers
The most important include:
- telomere length – telomeres shorten with subsequent cell divisions;
- DNA methylation – constitutes the basis of so-called epigenetic clocks;
- expression of genes related to repair and inflammatory processes;
- level of DNA damage proteins.
Epigenetic clocks, such as Horvath Clock or GrimAge, are currently among the most precise methods for assessing biological age.
Metabolic biomarkers
They reflect the metabolic efficiency of the body and include, among others:
- glucose and insulin levels,
- HOMA-IR index,
- lipid profile,
- adiponectin and leptin concentration,
- markers of mitochondrial function.
Metabolic abnormalities often correlate with accelerated aging and an increased risk of chronic diseases.
Inflammatory biomarkers
Chronic, low-grade inflammation is considered one of the primary mechanisms of aging. The most commonly measured markers are:
- high-sensitivity CRP (hs-CRP),
- interleukin 6 (IL-6),
- TNF-α,
- fibrinogen.
Elevated values of these parameters are associated with a higher risk of cardiovascular and neurodegenerative diseases, as well as skin degeneration.
Oxidative biomarkers
Oxidative stress leads to damage of lipids, proteins, and DNA. Diagnostics include the measurement of, among others:
- lipid peroxidation products,
- glutathione level,
- superoxide dismutase activity,
- 8-OHdG (a marker of DNA damage).
Functional biomarkers
They include parameters evaluating the body's fitness, such as:
- muscle strength,
- respiratory capacity,
- VO₂ max,
- body composition,
- bone mineral density.
In geriatrics, functional biomarkers often predict lifespan better than chronological age.
Biomarkers of aging – how to interpret the results?
Interpretation of aging biomarkers requires a multifactorial approach. A single parameter rarely provides a full picture of the biological processes occurring in the body. Biomarker panels analyzed collectively have significantly greater diagnostic value.
Comparing results with the following is of key importance:
- population norms,
- chronological age,
- sex,
- lifestyle,
- presence of chronic diseases,
- level of physical activity.
For example:
- shortened telomeres may indicate accelerated cellular aging,
- high hs-CRP suggests chronic inflammation,
- DNA methylation disturbances may reflect increased biological age,
- insulin resistance often correlates with faster metabolic aging.
It should be remembered, however, that biomarkers remain dynamic and are subject to the influence of:
- diet,
- sleep quality,
- physical activity,
- chronic stress,
- environmental exposure,
- tobacco smoking,
- hormonal and pharmacological therapies.
In longevity medicine, monitoring changes in biomarkers over time is of particular importance. This allows for the assessment of the effectiveness of preventive and therapeutic measures.
Artificial intelligence algorithms that integrate multiple biological parameters to precisely determine the organism's biological age are also increasingly being used.
Biomarkers of aging – application in longevity diagnostics
Longevity medicine focuses on extending the healthspan rather than just the lifespan. Biomarkers of aging are a fundamental tool in this field.
Their application includes:
Biological age assessment
It allows determining whether the body is aging faster or slower than indicated by chronological age. A person aged 45 may biologically correspond to a thirty-year-old or, conversely, a sixty-year-old.
Early detection of disease risk
Changes in biomarkers often appear earlier than clinical symptoms. This allows for earlier implementation of preventive measures.
This particularly applies to:
- cardiovascular diseases,
- type 2 diabetes,
- neurodegeneration,
- osteoporosis,
- autoimmune diseases.
Personalization of therapies
Biomarker analysis enables individual tailoring of:
- supplementation,
- hormone therapies,
- nutritional programs,
- physical activity,
- anti-aging procedures.
Monitoring the effectiveness of interventions
A reduction in inflammatory markers, improvement in metabolic parameters, or slowing of the epigenetic clock can indicate the effectiveness of implemented therapies.
In clinical practice, longevity diagnostics increasingly combine:
- laboratory tests,
- genetic analysis,
- microbiome assessment,
- hormonal diagnostics,
- body composition analysis,
- skin quality assessment.
This approach allows for obtaining a multidimensional picture of the body's aging processes.
Biomarkers of aging – skin-specific markers
Skin is one of the most visible organs of the aging organism. Aging processes include both intrinsic (chronological) and extrinsic aging, mainly related to UV radiation, oxidative stress, and environmental pollution.
The most important biomarkers of skin aging include:
Collagen degradation markers
A decrease in the amount of type I and III collagen leads to:
- loss of firmness,
- wrinkle formation,
- skin laxity.
Matrix metalloproteinases (MMPs) play a significant role, as they intensify the degradation of the skin's support fibers.
Oxidative stress markers
UV radiation increases the production of free radicals that damage skin cells. Studies evaluate, among others:
- the level of reactive oxygen species (ROS),
- damage to cell membrane lipids,
- oxidative DNA damage.
Skin inflammation markers
Chronic micro-inflammation accelerates the degradation of skin structures and disrupts regeneration. Of significance are, among others:
- IL-1,
- IL-6,
- TNF-α.
Skin barrier function biomarkers
The following are evaluated:
- hydration level,
- transepidermal water loss (TEWL),
- ceramide content,
- integrity of the hydrolipid mantle.
Glycation biomarkers
Advanced glycation end-products (AGEs) cause stiffness of collagen fibers and deterioration of skin quality. The glycation process is intensified by a diet rich in simple sugars and chronic oxidative stress.
In dermatology and aesthetic medicine, skin aging biomarkers are used to plan therapies such as:
- collagen biostimulation,
- regenerative mesotherapy,
- laser therapies,
- microneedling radiofrequency,
- exosome therapies,
- procedures improving epidermal barrier function.
In clinical practice, a personalized approach to skin aging is gaining importance, taking into account both the patient's genetic predispositions and the influence of the environment and lifestyle.